Showing results (791-800 of 1,242) with videos related to

Sort By:
Pageof 125
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 1, 2015
Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosisJ A Liberty Jenkins, Sarada Sakamuri, Jonathan S Katz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 8, 2017
Spanish adaptation of the edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS)Jesús S Mora, Teresa Salas, María Camino Fernández, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2017
Intrafamilial phenotypic variations in familial cases of cervical flexion induced myelopathy/Hirayama diseaseKiran Polavarapu, Veeramani Preethish-Kumar, Saraswati Nashi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2016
The role of the FTD-ALS associated C9orf72 expansion in suicide victimsEino Solje, Pirkko Riipinen, Seppo Helisalmi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 12, 2017
Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insuranceLisa Meng, Amy Bian, Scott Jordan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 10, 2017
Riluzole does not improve lifespan or motor function in three ALS mouse modelsMarion C Hogg, Luise Halang, Ina Woods, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 2, 2018
Phenotypic and genotypic studies of ALS cases in ALS-SMA familiesPhilippe Corcia, Patrick Vourc'h, Helene Blasco, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 16, 2018
Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspectiveCrystal Jing Jing Yeo, Zachary Simmons
Pageof 125